Literature DB >> 19091289

Serotonin syndrome in a patient taking Lexapro and Flexeril: a case report.

Luke T Day1, Rebecca K Jeanmonod.   

Abstract

The serotonin syndrome is a rare toxicological emergency increasingly seen in emergency practice, secondary to increased use of proserotinergic drugs. In this case report, the condition is described in a patient taking the selective serotonin reuptake inhibitor Lexapro and the muscle-relaxant Flexeril. Based on this case, Cyclobenzaprine should be considered on the growing list of medications that can precipitate the serotonin syndrome. With the increasing prevalence of proserotinergic polypharmacy, this uncommon toxidrome should be considered by the alert emergency medicine physician.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091289     DOI: 10.1016/j.ajem.2008.03.028

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

2.  Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome.

Authors:  J Mestres; S A Seifert; T I Oprea
Journal:  Clin Pharmacol Ther       Date:  2011-10-05       Impact factor: 6.875

3.  An interesting case of serotonin syndrome precipitated by escitalopram.

Authors:  Debasish Sanyal; Suddhendu Chakraborty; Ranjan Bhattacharyya
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

4.  Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report.

Authors:  Yasushi Sato; Kazuhiko Nakamura; Norio Yasui-Furukori
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-30       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.